Abstract
Subcortical vascular cognitive impairment (SVCI) refers to the cognitive impairment associated with small vessel diseases (SVD), which encompasses both subcortical vascular mild cognitive impairment (svMCI) and subcortical ischemic vascular dementia (SVaD). The recent development of modern MRI techniques such as diffusion tensor imaging (DTI) or resting-state functional MRI (rs-fMRI) has allowed researchers to investigate neuroimaging characteristics related to the mechanisms that underlie cognitive dysfunctions in SVCI. Although ischemia is regarded as the primary underlying pathology of SVCI, one of the major concerns regarding diagnosis and research for SVCI is that the large proportion of clinically diagnosed SVCI patients often reveals concomitant Alzheimer’s disease pathology. With the recent availability of amyloid positron emission tomography (PET), the identification of pure SVCI has provided further insights into neuroimaging characteristics of pure SVCI. Here, this section will introduce an overview of the structural and functional neuroimaging characteristics of SVCI based on recent neuroimaging studies with MRI, especially focused on pure SVCI.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Román GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1(7):426–36.
Hong YJ, Kim CM, Kim JE, et al. Regional amyloid burden and lacune in pure subcortical vascular cognitive impairment. Neurobiol Aging. 2017;55:20–6.
Kim SH, Park JS, Ahn HJ, et al. Voxel-based analysis of diffusion tensor imaging in patients with subcortical vascular cognitive impairment: correlates with cognitive and motor deficits. J Neuroimaging. 2011;21(4):317–24.
Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. J Neurol Sci. 2007;257(1):80–7.
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55(3):306–19.
Lee JH, Kim SH, Kim GH, et al. Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology. 2011;77(1):18–25.
Erkinjuntti T, Inzitari D, Pantoni L, et al. Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? Ann N Y Acad Sci. 2000;903:262–72.
Jeong JH, Kim EJ, Seo SW, et al. Cognitive and behavioral abnormalities of vascular cognitive impairment. In: Miller BL, Boeve BF, editors. The behavioral neurology of dementia. Cambridge: Cambridge University Press; 2016. p. 301–30.
Kim GH, Lee JH, Seo SW, et al. Seoul criteria for PiB(−) subcortical vascular dementia based on clinical and MRI variables. Neurology. 2014;82(17):1529–35.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text revision ed. American Psychiatric Association: Washington, DC; 1994.
Dichgans M, Leys D. Vascular cognitive impairment. Circ Res. 2017;120(3):573–91.
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.
Aung WY, Mar S, Benzinger TL. Diffusion tensor MRI as a biomarker in axonal and myelin damage. Imaging Med. 2013;5(5):427–40.
Zarei M, Damoiseaux JS, Morgese C, et al. Regional white matter integrity differentiates between vascular dementia and Alzheimer disease. Stroke. 2009;40(3):773–9.
Zhou Y, Qun X, Qin LD, et al. A primary study of diffusion tensor imaging-based histogram analysis in vascular cognitive impairment with no dementia. Clin Neurol Neurosurg. 2011;113(2):92–7.
Zhou Y, Lin FC, Zhu J, et al. Whole brain diffusion tensor imaging histogram analysis in vascular cognitive impairment. J Neurol Sci. 2008;268(1–2):60–4.
Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage. 2006;31(4):1487–505.
Kim Y, Kwon H, Lee JM, et al. White matter microstructural changes in pure Alzheimer’s disease and subcortical vascular dementia. Eur J Neurol. 2015;22(4):709–16.
Jung NY, Han CE, Kim HJ, et al. Tract-specific correlates of neuropsychological deficits in patients with subcortical vascular cognitive impairment. J Alzheimer Dis. 2016;50(4):1125–35.
Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR Am J Neuroradiol. 1990;11(3):431–9.
Gootjes L, Teipel SJ, Zebuhr Y, et al. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer’s disease and healthy aging. Dement Geriatr Cogn Disord. 2004;18(2):180–8.
Wen W, Sachdev PS. Extent and distribution of white matter hyperintensities in stroke patients: the Sydney Stroke Study. Stroke. 2004;35(12):2813–9.
Bocti C, Swartz RH, Gao FQ, et al. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Stroke. 2005;36(10):2126–31.
Jung WB, Mun CW, Kim YH, et al. Cortical atrophy, reduced integrity of white matter and cognitive impairment in subcortical vascular dementia of Binswanger type. Psychiatry Clin Neurosci. 2014;68(12):821–32.
Tuladhar AM, van Norden AG, de Laat KF, et al. White matter integrity in small vessel disease is related to cognition. NeuroImage Clin. 2015;7:518–24.
de Laat KF, Tuladhar AM, van Norden AG, et al. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain. 2011;134(Pt 1):73–83.
Kim YJ, Kwon HK, Lee JM, et al. Gray and white matter changes linking cerebral small vessel disease to gait disturbances. Neurology. 2016;86(13):1199–207.
Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Supp. 2000;59:23–30.
Mungas D, Jagust WJ, Reed BR, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease. Neurology. 2001;57(12):2229–35.
Peres R, De Guio F, Chabriat H, et al. Alterations of the cerebral cortex in sporadic small vessel disease: a systematic review of in vivo MRI data. J Cereb Blood Flow Metab. 2016;36(4):681–95.
Gouw AA, Seewann A, van der Flier WM, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry. 2011;82(2):126–35.
Smith EE, Schneider JA, Wardlaw JM, et al. Cerebral microinfarcts: the invisible lesions. Lancet Neurol. 2012;11(3):272–82.
Duering M, Righart R, Wollenweber FA, et al. Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts. Neurology. 2015;84(16):1685–92.
Seo SW, Ahn J, Yoon U, et al. Cortical thinning in vascular mild cognitive impairment and vascular dementia of subcortical type. J Neuroimaging. 2010;20(1):37–45.
Lerch JP, Pruessner JC, Zijdenbos A, et al. Focal decline of cortical thickness in Alzheimer’s disease identified by computational neuroanatomy. Cereb Cortex. 2005;15(7):995–1001.
Singh V, Chertkow H, Lerch JP, et al. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer’s disease. Brain. 2006;129(11):2885–93.
Kim CH, Seo SW, Kim GH, et al. Cortical thinning in subcortical vascular dementia with negative 11C-PiB PET. J Alzheimer Dis. 2012;31(2):315–23.
Kim HJ, Ye BS, Yoon CW, et al. Cortical thickness and hippocampal shape in pure vascular mild cognitive impairment and dementia of subcortical type. Eur J Neurol. 2014;21(5):744–51.
Chui HC. Subcortical ischemic vascular dementia. Neurol Clin. 2007;25(3):717–40.
Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50(8):873–80.
Thong JY, Du J, Ratnarajah N, et al. Abnormalities of cortical thickness, subcortical shapes, and white matter integrity in subcortical vascular cognitive impairment. Hum Brain Mapp. 2014;35(5):2320–32.
Guimaraes JS, Freire MA, Lima RR, et al. Mechanisms of secondary degeneration in the central nervous system during acute neural disorders and white matter damage. Rev Neurol. 2009;48(6):304–10.
Wang JT, Medress ZA, Barres BA. Axon degeneration: molecular mechanisms of a self-destruction pathway. J Cell Biol. 2012;196(1):7–18.
Kovari E, Gold G, Herrmann FR, et al. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology. 2007;68(12):927–31.
Selden NR, Gitelman DR, Salamon-Murayama N, et al. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain. 1998;121(Pt 12):2249–57.
Tomimoto H, Ohtani R, Shibata M, et al. Loss of cholinergic pathways in vascular dementia of the Binswanger type. Dement Geriatr Cogn Disord. 2005;19(5–6):282–8.
Phillips OR, Clark KA, Woods RP, et al. Topographical relationships between arcuate fasciculus connectivity and cortical thickness. Hum Brain Mapp. 2011;32(11):1788–801.
Burton EJ, Barber R, Mukaetova-Ladinska EB, et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain. 2009;132(1):195–203.
Gosche KM, Mortimer JA, Smith CD, et al. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology. 2002;58(10):1476–82.
Du AT, Schuff N, Laakso MP, et al. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology. 2002;58(11):1635–41.
Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer’s disease, Parkinson’s disease with and without dementia, and in vascular dementia: an MRI study. Neurology. 1996;46(3):678–81.
Zarow C, Vinters HV, Ellis WG, et al. Correlates of hippocampal neuron number in Alzheimer’s disease and ischemic vascular dementia. Ann Neurol. 2005;57(6):896–903.
Kim GH, Lee JH, Seo SW, et al. Hippocampal volume and shape in pure subcortical vascular dementia. Neurobiol Aging. 2015;36(1):485–91.
Kim HJ, Kim J, Cho H, et al. Individual subject classification of mixed dementia from pure subcortical vascular dementia based on subcortical shape analysis. PLoS One. 2013;8(10):e75602.
Hagmann P, Cammoun L, Gigandet X, et al. Mapping the structural core of human cerebral cortex. PLoS Biol. 2008;6(7):e159.
Hagmann P, Kurant M, Gigandet X, et al. Mapping human whole-brain structural networks with diffusion MRI. PLoS One. 2007;2(7):e597.
Gong G, He Y, Concha L, et al. Mapping anatomical connectivity patterns of human cerebral cortex using in vivo diffusion tensor imaging tractography. Cereb Cortex. 2009;19(3):524–36.
Latora V, Marchiori M. Efficient behavior of small-world networks. Phys Rev Lett. 2001;87(19):198701.
Lawrence AJ, Chung AW, Morris RG, et al. Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology. 2014;83(4):304–11.
Tuladhar AM, van Dijk E, Zwiers MP, et al. Structural network connectivity and cognition in cerebral small vessel disease. Hum Brain Mapp. 2016;37(1):300–10.
Tuladhar AM, Reid AT, Shumskaya E, et al. Relationship between white matter hyperintensities, cortical thickness, and cognition. Stroke. 2015;46(2):425–32.
Kim HJ, Im K, Kwon H, et al. Clinical effect of white matter network disruption related to amyloid and small vessel disease. Neurology. 2015;85(1):63–70.
Tuladhar AM, van Uden IW, Rutten-Jacobs LC, et al. Structural network efficiency predicts conversion to dementia. Neurology. 2016;86(12):1112–9.
Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci. 2007;8(9):700–11.
Papma JM, den Heijer T, de Koning I, et al. The influence of cerebral small vessel disease on default mode network deactivation in mild cognitive impairment. NeuroImage Clin. 2012;2:33–42.
Yi L, Wang J, Jia L, et al. Structural and functional changes in subcortical vascular mild cognitive impairment: a combined voxel-based morphometry and resting-state fMRI study. PLoS One. 2012;7(9):e44758.
Ding W, Cao W, Wang Y, et al. Altered functional connectivity in patients with subcortical vascular cognitive impairment—a resting-state functional magnetic resonance imaging study. PLoS One. 2015;10(9):e0138180.
Liu C, Li C, Yin X, et al. Abnormal intrinsic brain activity patterns in patients with subcortical ischemic vascular dementia. PLoS One. 2014;9(2):e87880.
Zhou X, Hu X, Zhang C, et al. Aberrant functional connectivity and structural atrophy in subcortical vascular cognitive impairment: relationship with cognitive impairments. Front Aging Neurosci. 2016;8:14.
Kim HJ, Cha J, Lee JM, et al. Distinctive resting state network disruptions among Alzheimer’s disease, subcortical vascular dementia, and mixed dementia patients. J Alzheimers Dis. 2016;50(3):709–18.
Kim HJ, Yoon CW, Ye BS, Kim E-J, Seo SW, Jeong JH, Na DL. Vascular dementia. In: Dierckx RAJO, Otte A, de Vries EFJ, van Waarde A, Leenders KL, editors. PET and SPECT in neurology. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014. p. 417–35.
Nagata KEN, Maruya H, Yuya H, et al. Can PET data differentiate Alzheimer’s disease from vascular dementia? Ann N Y Acad Sci. 2000;903(1):252–61.
Brooks DJ. The clinical role of PET in cerebrovascular disease. Neurosurg Rev. 1991;14(2):91–6.
Kuwabara Y, Ichiya Y, Sasaki M, et al. Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography. Stroke. 1995;26(10):1825–9.
De Reuck J, Decoo D, Hasenbroekx MC, et al. Acetazolamide vasoreactivity in vascular dementia: a positron emission tomographic study. Eur Neurol. 1999;41(1):31–6.
Yao H, Sadoshima S, Kuwabara Y, et al. Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke. 1990;21(12):1694–9.
Tohgi H, Yonezawa H, Takahashi S, et al. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer’s type and vascular dementia with deep white matter changes. Neuroradiology. 1998;40(3):131–7.
Tohgi H, Chiba K, Sasaki K, et al. Cerebral perfusion patterns in vascular dementia of Binswanger type compared with senile dementia of Alzheimer type: a SPECT study. J Neurol. 1991;238(7):365–70.
Hanyu H, Shimuzu S, Tanaka Y, et al. Cerebral blood flow patterns in Binswanger’s disease: a SPECT study using three-dimensional stereotactic surface projections. J Neurol Sci. 2004;220(1–2):79–84.
Yang D-W, Kim B-S, Park J-K, et al. Analysis of cerebral blood flow of subcortical vascular dementia with single photon emission computed tomography: Adaptation of statistical parametric mapping. J Neurol Sci. 2002;203–204(Supplement C):199–205.
Shim YS, Yang DW, Kim BS, et al. Comparison of regional cerebral blood flow in two subsets of subcortical ischemic vascular dementia: statistical parametric mapping analysis of SPECT. J Neurol Sci. 2006;250(1–2):85–91.
Wahlund L-O, Bronge L, Savitcheva I, Axelsson R. Neuroimaging in vascular covnitive impairment: Structural and functional imaging in vascular dementia, Oxford textbook of neuroimaging. Oxford University Press, USA, 2015.
Mendez MF, Ottowitz W, Brown CV, et al. Dementia with leukoaraiosis: clinical differentiation by temporoparietal hypometabolism on (18)FDG-PET imaging. Dement Geriatr Cogn Disord. 1999;10(6):518–25.
Pascual B, Prieto E, Arbizu J, et al. Brain glucose metabolism in vascular white matter disease with dementia: differentiation from Alzheimer disease. Stroke. 2010;41(12):2889–93.
Kerrouche N, Herholz K, Mielke R, et al. 18FDG PET in vascular dementia: differentiation from Alzheimer’s disease using voxel-based multivariate analysis. J Cereb Blood Flow Metab. 2006;26(9):1213–21.
Seo SW, Cho SS, Park A, et al. Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism. J Neuroimaging. 2009;19(3):213–9.
Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology. 2004;63(2):246–53.
Suri S, Topiwala A, Mackay CE, et al. Using structural and diffusion magnetic resonance imaging to differentiate the dementias. Curr Neurol Neurosci Rep. 2014;14(9):475.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Kim, G.H., Hwang, J., Jeong, J.H. (2020). Neuroimaging Characteristics of Subcortical Vascular Cognitive Impairment. In: Lee, SH., Lim, JS. (eds) Stroke Revisited: Vascular Cognitive Impairment. Stroke Revisited. Springer, Singapore. https://doi.org/10.1007/978-981-10-1433-8_10
Download citation
DOI: https://doi.org/10.1007/978-981-10-1433-8_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-1432-1
Online ISBN: 978-981-10-1433-8
eBook Packages: MedicineMedicine (R0)